Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.04 trillion and total revenue of $110.14 billion.
Market Cap
1.04T
Revenue
110.14B
Profits
-41.3B
PE Ratio
n/a
Profit Margin
-37.50%
Dividend Yield
0.05%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.01B | -4.56% | 1,918,938 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.70B | -2.51% | 492,103 | 14.34B |
| 3 | ARGX | argenx SE | 43.43B | -0.21% | 419,033 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.09B | -3.29% | 815,892 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 31.38B | 2.20% | 233,828 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.32B | -1.56% | 3,402,099 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.74B | -1.26% | 2,710,159 | 2.38B |
| 8 | BNTX | BioNTech SE | 20.56B | -2.04% | 705,981 | 3.37B |
| 9 | MRNA | Moderna, Inc. | 19.65B | -7.49% | 7,098,932 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 18.98B | -3.03% | 3,012,871 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 18.33B | -0.75% | 1,102,724 | - |
| 12 | INCY | Incyte Corporation | 17.97B | -2.12% | 1,494,336 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.93B | -0.81% | 1,816,056 | 3.72B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 13.51B | -3.97% | 1,225,204 | 502.08M |
| 15 | ASND | Ascendis Pharma A/S | 13.32B | -1.65% | 580,803 | 845.52M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.86B | -3.94% | 2,079,560 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.92B | -2.82% | 1,948,253 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.71B | -1.56% | 487,137 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.25B | -3.42% | 826,952 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.79B | -1.96% | 1,762,429 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.41B | -2.54% | 1,345,747 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 8.14B | -6.40% | 1,757,499 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.09B | -4.92% | 1,650,505 | 1.09B |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.08B | -4.16% | 398,727 | 7.46M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.00B | -4.82% | 680,798 | 638.50M |
| 26 | TECH | Bio-Techne Corporation | 7.97B | -3.32% | 1,787,407 | 1.22B |
| 27 | CYTK | Cytokinetics, Incorporated | 7.70B | -1.54% | 1,701,712 | 88.04M |
| 28 | PCVX | Vaxcyte, Inc. | 7.65B | -2.83% | 995,884 | - |
| 29 | NUVL | Nuvalent, Inc. | 7.60B | -1.43% | 482,661 | - |
| 30 | IBRX | ImmunityBio, Inc. | 7.59B | - | 14,454,915 | 113.29M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.30B | -2.62% | 1,282,880 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.17B | -2.39% | 289,700 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.72B | -0.04% | 1,653,379 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.38B | -2.52% | 671,414 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.32B | -3.13% | 785,488 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 5.98B | 1.94% | 109,773 | - |
| 37 | TERN | Terns Pharmaceuticals, Inc. | 5.98B | -0.47% | 7,922,820 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 5.81B | -2.09% | 1,542,830 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 5.75B | -0.77% | 1,529,257 | - |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.47B | -1.30% | 1,036,445 | 1.73B |
| 41 | CGON | CG Oncology, Inc. | 5.46B | -3.07% | 889,230 | 4.04M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.34B | -0.50% | 969,246 | 521.31M |
| 43 | XENE | Xenon Pharmaceuticals Inc. | 5.20B | -1.89% | 966,676 | 7.50M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.18B | -7.42% | 1,424,817 | 189.76M |
| 45 | CELC | Celcuity Inc. | 5.12B | -7.66% | 1,074,236 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 4.89B | -3.64% | 1,056,895 | - |
| 47 | IMVT | Immunovant, Inc. | 4.88B | -5.44% | 1,133,121 | - |
| 48 | CAI | Caris Life Sciences, Inc. | 4.79B | -7.53% | 3,710,972 | 812.03M |
| 49 | TGTX | TG Therapeutics, Inc. | 4.69B | -0.72% | 1,523,772 | 616.29M |
| 50 | ERAS | Erasca, Inc. | 4.65B | -1.25% | 3,870,212 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.52B | -0.14% | 2,288,924 | 634.21M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.39B | -3.79% | 1,594,424 | 3.51M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.30B | -1.60% | 1,689,173 | 2.04M |
| 54 | CNTA | Centessa Pharmaceuticals plc | 4.19B | -2.38% | 1,385,352 | 15.00M |
| 55 | CORT | Corcept Therapeutics Incorporated | 4.00B | -2.41% | 1,775,226 | 761.41M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.90B | -4.04% | 268,255 | 268.09M |
| 57 | VKTX | Viking Therapeutics, Inc. | 3.76B | -5.05% | 2,251,288 | - |
| 58 | SYRE | Spyre Therapeutics, Inc. | 3.72B | -0.44% | 832,414 | - |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.54B | -3.35% | 1,214,753 | 1.07B |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.53B | -7.27% | 1,461,482 | 7.70M |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.45B | -4.06% | 743,739 | 22.50M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.31B | -2.56% | 565,574 | - |
| 63 | GPCR | Structure Therapeutics Inc. | 3.25B | -0.61% | 1,299,952 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.19B | 2.56% | 269,328 | 803.79M |
| 65 | ALMS | Alumis Inc. | 3.15B | -5.78% | 1,549,317 | 24.05M |
| 66 | LEGN | Legend Biotech Corporation | 3.11B | -3.95% | 1,307,503 | 1.03B |
| 67 | DNLI | Denali Therapeutics Inc. | 2.88B | -8.00% | 3,068,747 | - |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.86B | -3.51% | 754,767 | 588.99M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.83B | -7.60% | 1,763,867 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 2.82B | -1.41% | 356,356 | 451.36M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.80B | -2.87% | 1,413,338 | 70.85M |
| 72 | VERA | Vera Therapeutics, Inc. | 2.77B | -3.48% | 763,120 | - |
| 73 | TNGX | Tango Therapeutics, Inc. | 2.75B | -3.02% | 1,836,172 | 62.38M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.67B | -5.08% | 693,897 | 218.71M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.63B | -5.18% | 1,357,045 | 376.07M |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.54B | -4.38% | 734,637 | 247.00M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.51B | -2.40% | 633,440 | 490.73M |
| 78 | MANE | Veradermics, Incorporated | 2.45B | -2.99% | 261,758 | - |
| 79 | ELVN | Enliven Therapeutics, Inc. | 2.32B | -1.17% | 1,347,898 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.29B | -3.10% | 318,198 | - |
| 81 | KOD | Kodiak Sciences Inc. | 2.29B | -6.94% | 5,262,726 | - |
| 82 | IMNM | Immunome, Inc. | 2.22B | -3.92% | 1,189,158 | 6.94M |
| 83 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.05% | 2,368,063 | 158.18M |
| 84 | BEAM | Beam Therapeutics Inc. | 2.20B | -6.05% | 2,626,267 | 139.74M |
| 85 | ORKA | Oruka Therapeutics, Inc. | 2.20B | -2.16% | 885,313 | - |
| 86 | ADMA | ADMA Biologics, Inc. | 2.20B | 11.58% | 22,370,956 | 510.17M |
| 87 | APLS | Apellis Pharmaceuticals, Inc. | 2.17B | -3.80% | 1,762,706 | 1.00B |
| 88 | AAPG | Ascentage Pharma Group International | 2.16B | 8.17% | 3,751 | 82.08M |
| 89 | SRPT | Sarepta Therapeutics, Inc. | 2.10B | -7.89% | 4,609,413 | 2.20B |
| 90 | SNDX | Syndax Pharmaceuticals, Inc. | 2.07B | -4.90% | 1,234,523 | 172.35M |
| 91 | ZLAB | Zai Lab Limited | 2.02B | 2.80% | 691,911 | 460.16M |
| 92 | CLDX | Celldex Therapeutics, Inc. | 2.02B | -4.57% | 904,818 | 1.55M |
| 93 | NKTR | Nektar Therapeutics | 1.97B | -3.25% | 735,798 | 55.23M |
| 94 | TYRA | Tyra Biosciences, Inc. | 1.95B | -4.58% | 671,875 | - |
| 95 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | 0.30% | 1,443,735 | - |
| 96 | STOK | Stoke Therapeutics, Inc. | 1.94B | -2.52% | 500,645 | 184.42M |
| 97 | GLPG | Galapagos NV | 1.93B | -3.47% | 371,321 | 1.31B |
| 98 | ADPT | Adaptive Biotechnologies Corporation | 1.91B | -11.10% | 4,947,809 | 276.98M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.90B | -2.26% | 1,130,886 | 283.06M |
| 100 | MESO | Mesoblast Limited | 1.88B | -3.36% | 176,068 | 65.38M |
| 101 | RARE | Ultragenyx Pharmaceutical Inc. | 1.87B | -3.10% | 1,529,974 | 673.00M |
| 102 | ZYME | Zymeworks Inc. | 1.78B | -2.07% | 429,429 | 105.97M |
| 103 | DFTX | Definium Therapeutics, Inc. | 1.78B | -5.60% | 1,742,740 | - |
| 104 | PHVS | Pharvaris N.V. | 1.78B | 0.04% | 55,922 | - |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.72B | -1.74% | 797,075 | 54.03M |
| 106 | RLAY | Relay Therapeutics, Inc. | 1.72B | -5.14% | 2,078,803 | 15.36M |
| 107 | INVA | Innoviva, Inc. | 1.68B | - | 496,970 | 411.33M |
| 108 | CAPR | Capricor Therapeutics, Inc. | 1.66B | -3.51% | 909,350 | 11.13M |
| 109 | ANAB | AnaptysBio, Inc. | 1.65B | -11.68% | 1,353,316 | 234.60M |
| 110 | OCUL | Ocular Therapeutix, Inc. | 1.64B | -6.44% | 2,822,709 | 51.95M |
| 111 | SION | Sionna Therapeutics, Inc. | 1.63B | -4.93% | 497,922 | - |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.55B | -6.67% | 19,285,924 | 74.68M |
| 113 | SLNO | Soleno Therapeutics, Inc. | 1.55B | -5.68% | 1,755,947 | 190.41M |
| 114 | DMRA | Damora Therapeutics, Inc. | 1.54B | -0.51% | 171,714 | - |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.54B | -3.28% | 683,688 | 868.45M |
| 116 | NRIX | Nurix Therapeutics, Inc. | 1.53B | -4.96% | 1,177,855 | 83.98M |
| 117 | MAZE | Maze Therapeutics, Inc. | 1.51B | -4.19% | 1,713,764 | 2.50M |
| 118 | PVLA | Palvella Therapeutics, Inc. | 1.51B | -4.46% | 229,062 | - |
| 119 | VCEL | Vericel Corporation | 1.49B | -4.80% | 732,677 | 276.26M |
| 120 | IMCR | Immunocore Holdings plc | 1.49B | -3.51% | 382,919 | 400.02M |
| 121 | NBTX | Nanobiotix S.A. | 1.48B | -3.44% | 58,700 | 11.93M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.46B | -6.57% | 3,735,320 | 67.67M |
| 123 | OCS | Oculis Holding AG | 1.46B | -1.20% | 126,145 | 1.51M |
| 124 | GENB | Generate Biomedicines, Inc. | 1.46B | -10.97% | 298,012 | 31.89M |
| 125 | NUVB | Nuvation Bio Inc. | 1.46B | -3.85% | 4,154,475 | 62.90M |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.45B | -3.98% | 1,429,336 | - |
| 127 | IOVA | Iovance Biotherapeutics, Inc. | 1.45B | -4.88% | 8,496,846 | 263.50M |
| 128 | NVAX | Novavax, Inc. | 1.38B | -5.59% | 3,942,281 | 1.12B |
| 129 | MBX | MBX Biosciences, Inc. | 1.35B | 0.74% | 352,809 | - |
| 130 | ARDX | Ardelyx, Inc. | 1.34B | -3.69% | 2,520,454 | 407.32M |
| 131 | VIR | Vir Biotechnology, Inc. | 1.34B | -6.25% | 1,459,157 | 68.56M |
| 132 | RAPP | Rapport Therapeutics, Inc. | 1.33B | -4.00% | 291,570 | - |
| 133 | SVRA | Savara Inc. | 1.30B | -2.10% | 1,550,983 | - |
| 134 | PGEN | Precigen, Inc. | 1.30B | -5.66% | 7,072,136 | 9.68M |
| 135 | BHVN | Biohaven Ltd. | 1.26B | -6.17% | 1,646,590 | - |
| 136 | IMTX | Immatics N.V. | 1.26B | -4.09% | 313,125 | 56.67M |
| 137 | MLTX | MoonLake Immunotherapeutics | 1.24B | -2.42% | 478,952 | - |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.23B | -1.85% | 1,211,406 | 123.67M |
| 139 | ATAI | AtaiBeckley Inc. | 1.22B | -5.37% | 3,254,031 | 4.09M |
| 140 | ORIC | ORIC Pharmaceuticals, Inc. | 1.21B | -2.58% | 1,347,015 | - |
| 141 | WVE | Wave Life Sciences Ltd. | 1.20B | 2.66% | 13,490,099 | 42.73M |
| 142 | BCAX | Bicara Therapeutics Inc. | 1.19B | -2.91% | 588,807 | - |
| 143 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -3.19% | 1,203,803 | - |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -0.43% | 1,114,049 | - |
| 145 | TSHA | Taysha Gene Therapies, Inc. | 1.17B | -5.79% | 2,277,045 | 9.77M |
| 146 | DBVT | DBV Technologies S.A. | 1.13B | -1.04% | 275,602 | 5.64M |
| 147 | PHAR | Pharming Group N.V. | 1.12B | - | 26,533 | 376.13M |
| 148 | IVA | Inventiva S.A. | 1.10B | -5.58% | 179,435 | 19.93M |
| 149 | SEPN | Septerna, Inc. | 1.07B | -3.52% | 145,381 | 45.95M |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.04B | -17.82% | 3,367,079 | 10.00M |
| 151 | EYPT | EyePoint, Inc. | 1.04B | -4.29% | 843,539 | 31.37M |
| 152 | ABCL | AbCellera Biologics Inc. | 991.33M | -2.39% | 2,368,603 | 75.13M |
| 153 | KALV | KalVista Pharmaceuticals, Inc. | 990.13M | 2.01% | 2,063,368 | 73.62M |
| 154 | CTMX | CytomX Therapeutics, Inc. | 977.12M | 2.26% | 7,537,407 | 76.20M |
| 155 | AVBP | ArriVent BioPharma, Inc. | 947.24M | -1.60% | 420,198 | - |
| 156 | CMPX | Compass Therapeutics, Inc. | 938.26M | -2.25% | 1,355,901 | 850.00K |
| 157 | XERS | Xeris Biopharma Holdings, Inc. | 931.13M | -3.05% | 1,364,204 | 291.85M |
| 158 | QURE | uniQure N.V. | 923.56M | -5.32% | 1,359,874 | 16.10M |
| 159 | GERN | Geron Corporation | 896.76M | -9.09% | 19,251,941 | 183.88M |
| 160 | INBX | Inhibrx Biosciences, Inc. | 852.90M | -11.25% | 293,812 | 1.30M |
| 161 | FTRE | Fortrea Holdings Inc. | 848.05M | -5.03% | 797,529 | 2.72B |
| 162 | ABUS | Arbutus Biopharma Corporation | 838.60M | -3.60% | 1,383,296 | 14.08M |
| 163 | XNCR | Xencor, Inc. | 837.53M | -7.23% | 845,999 | 125.58M |
| 164 | URGN | UroGen Pharma Ltd. | 835.87M | -4.08% | 827,277 | 109.79M |
| 165 | PHAT | Phathom Pharmaceuticals, Inc. | 833.69M | -1.95% | 1,502,478 | 175.11M |
| 166 | MPLT | MapLight Therapeutics, Inc. | 816.65M | -3.07% | 275,932 | - |
| 167 | GHRS | GH Research PLC | 815.69M | -6.67% | 87,784 | - |
| 168 | JANX | Janux Therapeutics, Inc. | 801.76M | -3.30% | 1,454,800 | 10.00M |
| 169 | SPRY | ARS Pharmaceuticals, Inc. | 801.33M | -5.72% | 2,382,159 | 84.28M |
| 170 | EVMN | Evommune, Inc. | 798.89M | -6.29% | 201,087 | 13.00M |
| 171 | AKTS | Aktis Oncology, Inc. | 797.81M | -13.79% | 577,073 | 5.56M |
| 172 | SLS | SELLAS Life Sciences Group, Inc. | 783.88M | -11.82% | 10,173,363 | - |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 777.76M | -6.00% | 607,569 | - |
| 174 | TBPH | Theravance Biopharma, Inc. | 776.51M | -0.72% | 574,141 | 107.46M |
| 175 | SGP | SpyGlass Pharma, Inc. | 753.31M | -10.28% | 95,373 | - |
| 176 | TENX | Tenax Therapeutics, Inc. | 749.48M | -0.47% | 360,686 | - |
| 177 | ANNX | Annexon, Inc. | 745.28M | -4.76% | 1,751,831 | - |
| 178 | SANA | Sana Biotechnology, Inc. | 739.22M | -8.58% | 2,587,141 | - |
| 179 | MRVI | Maravai LifeSciences Holdings, Inc. | 735.21M | -7.44% | 2,412,137 | 185.74M |
| 180 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 710.69M | -3.79% | 143,684 | - |
| 181 | MNKD | MannKind Corporation | 702.47M | -0.87% | 5,603,884 | 348.97M |
| 182 | OMER | Omeros Corporation | 700.50M | -4.08% | 876,911 | - |
| 183 | SLDB | Solid Biosciences Inc. | 699.56M | -8.02% | 826,503 | - |
| 184 | LXRX | Lexicon Pharmaceuticals, Inc. | 699.07M | 1.23% | 1,713,740 | 49.80M |
| 185 | DRUG | Bright Minds Biosciences Inc. | 685.13M | -4.38% | 177,863 | - |
| 186 | KURA | Kura Oncology, Inc. | 683.67M | -7.42% | 2,196,940 | 67.48M |
| 187 | RLMD | Relmada Therapeutics, Inc. | 674.44M | -1.53% | 739,613 | - |
| 188 | JBIO | Jade Biosciences, Inc. | 660.35M | -4.01% | 214,586 | - |
| 189 | ANRO | Alto Neuroscience, Inc. | 654.88M | -1.54% | 201,841 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 649.41M | -1.59% | 184,542 | - |
| 191 | ARVN | Arvinas, Inc. | 646.01M | -7.08% | 828,478 | 262.60M |
| 192 | OCGN | Ocugen, Inc. | 631.87M | -4.59% | 6,239,410 | 4.41M |
| 193 | GYRE | Gyre Therapeutics, Inc. | 619.11M | -3.69% | 158,665 | 116.59M |
| 194 | MGTX | MeiraGTx Holdings plc | 618.14M | 1.20% | 566,475 | 81.39M |
| 195 | DRTS | Alpha Tau Medical Ltd. | 603.75M | -0.58% | 236,331 | - |
| 196 | LBRX | LB Pharmaceuticals Inc | 603.13M | -2.81% | 173,859 | - |
| 197 | VOR | Vor Biopharma Inc. | 601.21M | 6.71% | 1,715,851 | - |
| 198 | PRME | Prime Medicine, Inc. | 598.53M | -7.14% | 4,075,646 | 4.63M |
| 199 | REPL | Replimune Group, Inc. | 596.17M | -4.24% | 1,196,144 | - |
| 200 | MDXG | MiMedx Group, Inc. | 566.04M | -3.30% | 1,266,730 | 418.63M |
| 201 | ZURA | Zura Bio Limited | 562.64M | -1.82% | 703,589 | - |
| 202 | VALN | Valneva SE | 552.89M | -2.37% | 16,978 | 205.07M |
| 203 | TECX | Tectonic Therapeutic, Inc. | 551.09M | -4.58% | 157,655 | - |
| 204 | ALLO | Allogene Therapeutics, Inc. | 550.94M | -6.22% | 6,330,340 | 22.00K |
| 205 | YDES | YD Bio Limited | 549.20M | 3.23% | 1,789 | 510.36K |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 537.80M | -2.55% | 519,787 | 106.47M |
| 207 | CRMD | CorMedix Inc. | 530.43M | 0.15% | 1,512,969 | 311.71M |
| 208 | EIKN | Eikon Therapeutics, Inc. | 529.59M | -6.84% | 201,458 | - |
| 209 | AGMB | AgomAb Therapeutics NV | 528.79M | -8.59% | 67,751 | - |
| 210 | CBIO | Crescent Biopharma, Inc. | 503.52M | 12.30% | 428,494 | 10.84M |
| 211 | PRTA | Prothena Corporation plc | 498.49M | -2.73% | 430,062 | 9.68M |
| 212 | CTNM | Contineum Therapeutics, Inc. | 498.06M | -2.27% | 168,819 | - |
| 213 | ACRS | Aclaris Therapeutics, Inc. | 489.26M | - | 2,387,967 | 7.83M |
| 214 | PROK | ProKidney Corp. | 483.07M | -9.60% | 1,509,307 | 893.00K |
| 215 | LRMR | Larimar Therapeutics, Inc. | 479.94M | -4.74% | 1,044,709 | - |
| 216 | VTVT | vTv Therapeutics Inc. | 477.89M | 1.88% | 32,937 | 17.00K |
| 217 | RIGL | Rigel Pharmaceuticals, Inc. | 476.79M | -2.01% | 269,240 | 294.28M |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 476.31M | -8.35% | 1,059,686 | 85.21M |
| 219 | UPB | Upstream Bio, Inc. | 471.82M | -11.44% | 939,762 | 2.85M |
| 220 | KYTX | Kyverna Therapeutics, Inc. | 471.04M | -2.86% | 688,353 | - |
| 221 | ADCT | ADC Therapeutics SA | 470.06M | -6.57% | 1,005,361 | 81.36M |
| 222 | LYEL | Lyell Immunopharma, Inc. | 458.45M | -2.72% | 38,709 | 36.00K |
| 223 | FBRX | Forte Biosciences, Inc. | 454.70M | -5.59% | 283,031 | - |
| 224 | FULC | Fulcrum Therapeutics, Inc. | 448.22M | -3.03% | 390,887 | 80.00M |
| 225 | VSTM | Verastem, Inc. | 442.69M | -4.73% | 1,653,203 | 30.91M |
| 226 | NAUT | Nautilus Biotechnology, Inc. | 440.44M | -7.94% | 431,436 | - |
| 227 | ASMB | Assembly Biosciences, Inc. | 439.40M | -4.05% | 70,466 | 72.30M |
| 228 | IMMX | Immix Biopharma, Inc. | 431.66M | -6.54% | 750,482 | - |
| 229 | STTK | Shattuck Labs, Inc. | 430.82M | -4.60% | 526,424 | 1.00M |
| 230 | TRDA | Entrada Therapeutics, Inc. | 429.48M | -3.09% | 126,796 | 25.42M |
| 231 | ENGN | enGene Holdings Inc. | 426.72M | -8.48% | 162,375 | - |
| 232 | ABSI | Absci Corporation | 425.40M | -3.47% | 4,206,305 | 2.80M |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 412.76M | -1.90% | 82,141 | - |
| 234 | RCKT | Rocket Pharmaceuticals, Inc. | 409.31M | -19.62% | 23,207,222 | - |
| 235 | VNDA | Vanda Pharmaceuticals Inc. | 408.44M | -2.95% | 1,234,926 | 216.11M |
| 236 | AVIR | Atea Pharmaceuticals, Inc. | 407.92M | -3.94% | 320,120 | - |
| 237 | STRO | Sutro Biopharma, Inc. | 404.74M | -1.08% | 91,840 | 102.48M |
| 238 | RGNX | REGENXBIO Inc. | 400.52M | -6.05% | 630,783 | 170.44M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 398.51M | -3.36% | 881,161 | - |
| 240 | AURA | Aura Biosciences, Inc. | 398.17M | -2.64% | 275,914 | - |
| 241 | NMRA | Neumora Therapeutics, Inc. | 395.96M | -6.43% | 953,402 | - |
| 242 | ALT | Altimmune, Inc. | 392.92M | -5.63% | 2,674,890 | 41.00K |
| 243 | IVVD | Invivyd, Inc. | 387.15M | -9.27% | 2,577,626 | 53.43M |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 371.14M | -2.61% | 1,006,922 | 14.56M |
| 245 | PLYX | Polaryx Therapeutics, Inc. | 368.80M | 22.10% | 2,616,627 | - |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 367.32M | -6.26% | 320,161 | 35.11M |
| 247 | DMAC | DiaMedica Therapeutics Inc. | 363.80M | -0.88% | 180,929 | - |
| 248 | IPSC | Century Therapeutics, Inc. | 363.04M | -1.94% | 1,549,879 | 109.16M |
| 249 | MNPR | Monopar Therapeutics Inc. | 361.53M | -0.48% | 184,310 | - |
| 250 | XOMA | XOMA Royalty Corporation | 359.19M | -1.18% | 99,985 | 52.15M |
| 251 | PRTC | PureTech Health plc | 355.33M | -2.35% | 9,093 | 6.39M |
| 252 | ENTA | Enanta Pharmaceuticals, Inc. | 353.46M | -2.64% | 121,450 | 66.98M |
| 253 | CADL | Candel Therapeutics, Inc. | 352.32M | -1.43% | 1,327,853 | - |
| 254 | BNTC | Benitec Biopharma Inc. | 351.80M | -5.00% | 85,304 | - |
| 255 | DNA | Ginkgo Bioworks Holdings, Inc. | 345.17M | -7.49% | 1,627,348 | 170.16M |
| 256 | NAGE | Niagen Bioscience, Inc. | 337.04M | -6.04% | 1,081,797 | 129.42M |
| 257 | CLYM | Climb Bio, Inc. | 335.33M | -1.27% | 401,564 | - |
| 258 | SRZN | Surrozen, Inc. | 331.97M | 3.21% | 78,357 | 3.48M |
| 259 | PALI | Palisade Bio, Inc. | 331.77M | 2.04% | 3,525,484 | - |
| 260 | AUTL | Autolus Therapeutics plc | 322.03M | -6.20% | 4,847,890 | 75.39M |
| 261 | IMRX | Immuneering Corporation | 320.68M | -4.98% | 453,819 | - |
| 262 | NGNE | Neurogene Inc. | 316.94M | -4.95% | 108,389 | 925.00K |
| 263 | AVTX | Avalo Therapeutics, Inc. | 316.53M | -0.43% | 559,096 | 59.00K |
| 264 | PEPG | PepGen Inc. | 312.40M | -7.57% | 374,845 | - |
| 265 | RZLT | Rezolute, Inc. | 310.58M | -8.00% | 2,200,894 | - |
| 266 | IRD | Opus Genetics, Inc. | 309.50M | -3.76% | 336,963 | 14.20M |
| 267 | GLSI | Greenwich LifeSciences, Inc. | 309.37M | -11.88% | 207,436 | - |
| 268 | PBYI | Puma Biotechnology, Inc. | 309.33M | -3.03% | 229,626 | 228.37M |
| 269 | ARMP | Armata Pharmaceuticals, Inc. | 304.73M | -10.48% | 27,100 | 4.90M |
| 270 | OVID | Ovid Therapeutics Inc. | 303.31M | -6.50% | 2,037,600 | 7.25M |
| 271 | BCYC | Bicycle Therapeutics plc | 300.44M | -4.22% | 855,489 | 72.59M |
| 272 | CABA | Cabaletta Bio, Inc. | 298.34M | -4.96% | 2,799,899 | - |
| 273 | NBP | NovaBridge Biosciences | 292.84M | -0.39% | 472,445 | - |
| 274 | NGEN | NervGen Pharma Corp. | 291.52M | - | 256,897 | - |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 286.31M | 3.07% | 762,903 | 1.00 |
| 276 | SABS | SAB Biotherapeutics, Inc. | 270.56M | 0.52% | 808,550 | 114.70K |
| 277 | ALXO | ALX Oncology Holdings Inc. | 268.48M | - | 276,453 | - |
| 278 | ACIU | AC Immune SA | 267.84M | -6.57% | 260,545 | 4.51M |
| 279 | NERV | Minerva Neurosciences, Inc. | 267.44M | 0.65% | 167,779 | - |
| 280 | TARA | Protara Therapeutics, Inc. | 267.18M | -4.82% | 656,873 | - |
| 281 | FHTX | Foghorn Therapeutics Inc. | 264.15M | -8.16% | 85,349 | 30.91M |
| 282 | LENZ | LENZ Therapeutics, Inc. | 263.38M | -6.04% | 1,393,631 | 19.09M |
| 283 | AVXL | Anavex Life Sciences Corp. | 261.33M | -2.08% | 2,432,197 | - |
| 284 | SLGL | Sol-Gel Technologies Ltd. | 258.90M | - | 54,328 | 19.39M |
| 285 | PRLD | Prelude Therapeutics Incorporated | 251.73M | -5.86% | 119,068 | 12.14M |
| 286 | OBIO | Orchestra BioMed Holdings, Inc. | 249.30M | -5.12% | 137,069 | 33.48M |
| 287 | ENLV | Enlivex Ltd. | 249.25M | -3.67% | 230,927 | - |
| 288 | ABEO | Abeona Therapeutics Inc. | 244.74M | -0.92% | 1,167,770 | 5.82M |
| 289 | CHRS | Coherus Oncology, Inc. | 244.32M | -1.81% | 684,213 | 42.17M |
| 290 | ANL | Adlai Nortye Ltd. | 238.38M | -4.30% | 119,776 | -1.35M |
| 291 | CNTX | Context Therapeutics Inc. | 237.97M | 1.97% | 700,684 | - |
| 292 | VYGR | Voyager Therapeutics, Inc. | 236.01M | -4.12% | 401,662 | 40.37M |
| 293 | CCCC | C4 Therapeutics, Inc. | 235.16M | -8.02% | 1,632,669 | 35.95M |
| 294 | CLLS | Cellectis S.A. | 235.00M | -3.45% | 19,420 | 79.59M |
| 295 | SLN | Silence Therapeutics plc | 232.86M | -7.16% | 304,909 | 559.00K |
| 296 | HELP | Cybin Inc. | 226.16M | -2.80% | 561,287 | - |
| 297 | CAMP | Camp4 Therapeutics Corporation | 223.77M | -5.48% | 57,319 | 3.50M |
| 298 | ALEC | Alector, Inc. | 220.73M | -5.66% | 466,450 | 21.05M |
| 299 | OABI | OmniAb, Inc. | 218.62M | -4.43% | 236,780 | 18.67M |
| 300 | EDIT | Editas Medicine, Inc. | 218.25M | -3.88% | 1,652,692 | 40.52M |
| 301 | ELDN | Eledon Pharmaceuticals, Inc. | 214.98M | -4.39% | 864,219 | - |
| 302 | KROS | Keros Therapeutics, Inc. | 209.20M | -4.24% | 343,877 | 244.06M |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 203.75M | -9.22% | 203,472 | 44.64M |
| 304 | NVCT | Nuvectis Pharma, Inc. | 198.16M | -4.23% | 68,385 | - |
| 305 | MDWD | MediWound Ltd. | 193.17M | -4.20% | 123,200 | 16.96M |
| 306 | CGEN | Compugen Ltd. | 192.89M | -0.97% | 141,847 | 72.76M |
| 307 | CNTB | Connect Biopharma Holdings Limited | 192.87M | -6.50% | 347,860 | 762.00K |
| 308 | ARCT | Arcturus Therapeutics Holdings Inc. | 192.14M | -4.52% | 636,139 | 82.03M |
| 309 | ELTX | Elicio Therapeutics, Inc. | 192.06M | -3.51% | 82,169 | - |
| 310 | MGNX | MacroGenics, Inc. | 186.22M | -7.86% | 953,996 | 149.50M |
| 311 | ADAG | Adagene Inc. | 177.68M | -8.94% | 118,994 | 103.20K |
| 312 | GALT | Galectin Therapeutics Inc. | 172.79M | -4.29% | 331,450 | - |
| 313 | TNXP | Tonix Pharmaceuticals Holding Corp. | 172.66M | -6.33% | 766,750 | 13.11M |
| 314 | PLX | Protalix BioTherapeutics, Inc. | 172.42M | 1.42% | 749,256 | 52.74M |
| 315 | CRBU | Caribou Biosciences, Inc. | 172.01M | -6.81% | 896,001 | 11.16M |
| 316 | CNTN | Canton Strategic Holdings, Inc. | 163.31M | -0.94% | 391,470 | - |
| 317 | ABOS | Acumen Pharmaceuticals, Inc. | 163.20M | -11.37% | 924,538 | - |
| 318 | SGMT | Sagimet Biosciences Inc. | 159.34M | -4.31% | 575,493 | - |
| 319 | RNAC | Cartesian Therapeutics, Inc. | 155.08M | -3.78% | 321,725 | 2.80M |
| 320 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 154.48M | -5.74% | 214,747 | - |
| 321 | MOLN | Molecular Partners AG | 152.41M | -5.73% | 1,841 | 856.30K |
| 322 | HUMA | Humacyte, Inc. | 150.00M | -13.21% | 14,586,555 | 2.04M |
| 323 | KRRO | Korro Bio, Inc. | 149.99M | -4.67% | 127,073 | 6.39M |
| 324 | MENS | Jyong Biotech Ltd. | 149.19M | -3.96% | 75,686 | - |
| 325 | WHWK | Whitehawk Therapeutics, Inc. | 149.14M | -11.48% | 161,386 | 7.15M |
| 326 | DTIL | Precision BioSciences, Inc. | 148.85M | -7.95% | 534,115 | 34.26M |
| 327 | HRTX | Heron Therapeutics, Inc. | 147.76M | -5.02% | 1,901,226 | 154.90M |
| 328 | NKTX | Nkarta, Inc. | 146.86M | -3.74% | 754,102 | - |
| 329 | NTHI | NeOnc Technologies Holdings, Inc. | 145.52M | -0.14% | 10,628 | 59.99K |
| 330 | PRQR | ProQR Therapeutics N.V. | 144.34M | -8.67% | 566,464 | 19.19M |
| 331 | TNYA | Tenaya Therapeutics, Inc. | 144.33M | -5.11% | 2,291,103 | - |
| 332 | CDXS | Codexis, Inc. | 143.57M | -4.82% | 1,000,167 | 70.39M |
| 333 | CBUS | Cibus, Inc. | 143.20M | -11.74% | 1,913,902 | 3.64M |
| 334 | IMUX | Immunic, Inc. | 142.21M | -13.49% | 3,376,852 | - |
| 335 | ACHV | Achieve Life Sciences, Inc. | 141.09M | -8.30% | 1,234,058 | - |
| 336 | UNCY | Unicycive Therapeutics, Inc. | 137.33M | -3.62% | 552,470 | - |
| 337 | FATE | Fate Therapeutics, Inc. | 136.03M | -4.88% | 1,171,978 | 6.65M |
| 338 | ZNTL | Zentalis Pharmaceuticals, Inc. | 135.98M | -21.35% | 1,145,203 | 26.87M |
| 339 | PMN | ProMIS Neurosciences, Inc. | 132.18M | -2.58% | 31,679 | - |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 131.75M | -0.30% | 101,925 | 2.00M |
| 341 | ANTX | AN2 Therapeutics, Inc. | 131.54M | 1.39% | 264,219 | - |
| 342 | SPRO | Spero Therapeutics, Inc. | 131.27M | -1.69% | 498,713 | 66.80M |
| 343 | AGEN | Agenus Inc. | 130.17M | -1.45% | 321,617 | 114.20M |
| 344 | MIST | Milestone Pharmaceuticals Inc. | 127.56M | -9.57% | 2,939,928 | 1.55M |
| 345 | ARTV | Artiva Biotherapeutics, Inc. | 123.83M | -2.91% | 167,510 | 251.00K |
| 346 | KLRS | Kalaris Therapeutics, Inc. | 123.58M | -7.39% | 173,422 | - |
| 347 | KPTI | Karyopharm Therapeutics Inc. | 123.54M | -1.62% | 847,150 | 146.07M |
| 348 | SGMO | Sangamo Therapeutics, Inc. | 119.27M | -6.74% | 7,060,777 | 32.88M |
| 349 | EQ | Equillium, Inc. | 118.87M | -8.74% | 289,621 | 4.39M |
| 350 | IPHA | Innate Pharma S.A. | 118.78M | 4.00% | 67,907 | 10.57M |
| 351 | BDTX | Black Diamond Therapeutics, Inc. | 116.30M | -4.69% | 451,683 | 70.00M |
| 352 | INO | Inovio Pharmaceuticals, Inc. | 111.24M | 3.87% | 1,491,400 | 65.34K |
| 353 | ACOG | Alpha Cognition Inc. | 110.45M | -4.87% | 111,421 | 10.22M |
| 354 | GNLX | Genelux Corporation | 110.04M | -5.70% | 136,218 | 8.00K |
| 355 | HURA | TuHURA Biosciences, Inc. | 109.90M | -7.18% | 591,846 | - |
| 356 | ALDX | Aldeyra Therapeutics, Inc. | 106.52M | -3.80% | 2,608,689 | - |
| 357 | QTTB | Q32 Bio Inc. | 106.06M | 1.54% | 425,797 | 53.74M |
| 358 | CRDF | Cardiff Oncology, Inc. | 105.97M | -7.19% | 651,416 | 593.00K |
| 359 | TTRX | Turn Therapeutics Inc. | 101.88M | 1.76% | 39,246 | - |
| 360 | RANI | Rani Therapeutics Holdings, Inc. | 98.51M | -24.94% | 3,658,495 | 1.63M |
| 361 | BMEA | Biomea Fusion, Inc. | 95.44M | -3.65% | 1,851,823 | - |
| 362 | SEER | Seer, Inc. | 93.66M | -1.78% | 221,514 | 16.58M |
| 363 | COYA | Coya Therapeutics, Inc. | 92.89M | -5.26% | 251,407 | 7.95M |
| 364 | ONCY | Oncolytics Biotech Inc. | 90.39M | -6.77% | 1,697,030 | - |
| 365 | SPRB | Spruce Biosciences, Inc. | 86.49M | -8.78% | 38,103 | 697.00K |
| 366 | MCRB | Seres Therapeutics, Inc. | 86.28M | -3.54% | 30,097 | 789.00K |
| 367 | FBIO | Fortress Biotech, Inc. | 85.66M | -4.17% | 356,886 | 62.30M |
| 368 | ANIX | Anixa Biosciences, Inc. | 85.50M | -3.04% | 110,238 | - |
| 369 | LONA | LeonaBio, Inc. | 83.74M | -7.33% | 55,716 | - |
| 370 | PYXS | Pyxis Oncology, Inc. | 82.31M | -5.76% | 490,127 | 13.86M |
| 371 | KZIA | Kazia Therapeutics Limited | 81.82M | -1.38% | 177,896 | 1.27M |
| 372 | PYPD | PolyPid Ltd. | 81.68M | -0.69% | 51,330 | - |
| 373 | VANI | Vivani Medical, Inc. | 81.45M | -5.56% | 244,008 | - |
| 374 | GOSS | Gossamer Bio, Inc. | 81.32M | -7.55% | 9,486,985 | 48.47M |
| 375 | CSBR | Champions Oncology, Inc. | 79.71M | -0.86% | 11,340 | 57.95M |
| 376 | MAIA | MAIA Biotechnology, Inc. | 79.48M | -5.07% | 2,489,048 | - |
| 377 | AARD | Aardvark Therapeutics, Inc. | 77.45M | 1.14% | 225,108 | - |
| 378 | NRXS | NeurAxis, Inc. | 77.19M | -1.43% | 151,664 | 3.57M |
| 379 | PTHS | Pelthos Therapeutics Inc. | 75.47M | -1.10% | 4,674 | 16.80M |
| 380 | VRCA | Verrica Pharmaceuticals Inc. | 75.24M | -0.23% | 49,231 | 35.58M |
| 381 | CING | Cingulate Inc. | 74.31M | 1.75% | 370,692 | - |
| 382 | ATYR | aTyr Pharma, Inc. | 73.73M | -5.13% | 1,300,649 | 190.00K |
| 383 | PLRX | Pliant Therapeutics, Inc. | 72.44M | -4.88% | 726,663 | - |
| 384 | NRXP | NRx Pharmaceuticals, Inc. | 72.42M | -7.98% | 863,389 | 1.23M |
| 385 | GRCE | Grace Therapeutics, Inc. | 72.26M | -2.10% | 522,320 | - |
| 386 | GUTS | Fractyl Health, Inc. | 71.17M | -5.20% | 2,392,357 | 3.00K |
| 387 | GANX | Gain Therapeutics, Inc. | 70.39M | -3.17% | 890,931 | - |
| 388 | PMVP | PMV Pharmaceuticals, Inc. | 69.86M | -2.96% | 273,404 | - |
| 389 | ACET | Adicet Bio, Inc. | 69.55M | -3.86% | 105,067 | - |
| 390 | XBIT | XBiotech Inc. | 69.21M | -1.73% | 77,580 | - |
| 391 | MNOV | MediciNova, Inc. | 67.93M | -3.17% | 42,157 | 409.66K |
| 392 | COEP | Coeptis Therapeutics Holdings, Inc. | 66.46M | -2.20% | 20,990 | 1.36M |
| 393 | DWTX | Dogwood Therapeutics, Inc. | 66.14M | -4.81% | 67,112 | - |
| 394 | IFRX | InflaRx N.V. | 65.92M | -1.95% | 254,664 | 34.44K |
| 395 | BYSI | BeyondSpring Inc. | 65.80M | -0.62% | 22,363 | 1.88M |
| 396 | CGTX | Cognition Therapeutics, Inc. | 64.45M | -32.40% | 7,136,499 | - |
| 397 | IBO | Impact BioMedical Inc. | 61.98M | 1.79% | 112,877 | 32.00K |
| 398 | IBIO | iBio, Inc. | 60.80M | 1.15% | 1,265,216 | 300.00K |
| 399 | EXOZ | eXoZymes, Inc. | 60.06M | -1.11% | 5,571 | -700.00 |
| 400 | ATHE | Alterity Therapeutics Limited | 59.92M | - | 4,797 | 4.43M |
| 401 | ICCC | ImmuCell Corporation | 58.98M | -0.15% | 9,381 | 27.64M |
| 402 | ANVS | Annovis Bio, Inc. | 57.56M | -5.58% | 721,490 | - |
| 403 | TCRX | TScan Therapeutics, Inc. | 56.25M | -4.03% | 457,760 | 10.33M |
| 404 | IMA | ImageneBio, Inc. | 55.92M | -7.41% | 170,162 | 800.00K |
| 405 | OKUR | OnKure Therapeutics, Inc. | 54.56M | -13.07% | 7,061,487 | - |
| 406 | HYFT | MindWalk Holdings Corp. | 53.14M | -7.76% | 433,727 | 20.70M |
| 407 | TIL | Instil Bio, Inc. | 52.83M | -6.82% | 65,377 | - |
| 408 | MREO | Mereo BioPharma Group plc | 52.53M | -2.89% | 1,445,778 | 500.00K |
| 409 | LPCN | Lipocine Inc. | 52.19M | -3.38% | 65,021 | 1.98M |
| 410 | ENTX | Entera Bio Ltd. | 51.82M | 9.71% | 130,838 | 42.00K |
| 411 | IMMP | Immutep Limited | 51.74M | -2.11% | 447,319 | 5.28M |
| 412 | INKT | MiNK Therapeutics, Inc. | 51.73M | 14.43% | 229,282 | - |
| 413 | ACRV | Acrivon Therapeutics, Inc. | 51.53M | -6.34% | 594,603 | - |
| 414 | ACTU | Actuate Therapeutics, Inc. | 50.98M | -5.29% | 37,312 | - |
| 415 | RNXT | RenovoRx, Inc. | 50.95M | -2.59% | 534,031 | 928.00K |
| 416 | MGX | Metagenomi Therapeutics, Inc. | 49.66M | -5.04% | 264,622 | 25.21M |
| 417 | OSTX | OS Therapies Incorporated | 49.65M | 2.92% | 586,592 | - |
| 418 | RADX | Radiopharm Theranostics Limited | 48.82M | - | 83,886 | 10.86M |
| 419 | EDSA | Edesa Biotech, Inc. | 48.59M | -0.68% | 224,663 | - |
| 420 | XLO | Xilio Therapeutics, Inc. | 48.11M | -4.15% | 25,089 | 43.77M |
| 421 | NTRB | Nutriband Inc. | 46.92M | 0.26% | 7,045 | 2.28M |
| 422 | KZR | Kezar Life Sciences, Inc. | 45.70M | -2.36% | 27,369 | - |
| 423 | LSTA | Lisata Therapeutics, Inc. | 45.34M | - | 14,253 | 170.00K |
| 424 | ESLA | Estrella Immunopharma, Inc. | 44.80M | 0.96% | 32,387 | - |
| 425 | RLYB | Rallybio Corporation | 43.48M | -2.61% | 54,352 | 858.00K |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 42.98M | -0.79% | 81,986 | - |
| 427 | ALGS | Aligos Therapeutics, Inc. | 41.21M | -5.40% | 56,231 | 2.19M |
| 428 | ATOS | Atossa Therapeutics, Inc. | 40.65M | 0.21% | 64,845 | - |
| 429 | LITS | Lite Strategy, Inc. | 40.00M | -3.45% | 391,561 | - |
| 430 | NBY | NovaBay Pharmaceuticals, Inc. | 39.94M | -1.96% | 227,167 | 10.30M |
| 431 | PSTV | Plus Therapeutics, Inc. | 39.46M | -5.31% | 3,615,048 | 5.21M |
| 432 | HOWL | Werewolf Therapeutics, Inc. | 37.94M | -9.54% | 375,901 | 1.14M |
| 433 | ATRA | Atara Biotherapeutics, Inc. | 37.54M | -2.55% | 51,348 | 120.77M |
| 434 | APLM | Apollomics, Inc. | 37.06M | -2.10% | 4,470 | 6.93M |
| 435 | PTN | Palatin Technologies, Inc. | 36.33M | -3.20% | 9,579 | 8.96M |
| 436 | NXTC | NextCure, Inc. | 35.64M | -1.18% | 21,973 | - |
| 437 | CELU | Celularity Inc. | 35.18M | 1.67% | 26,235 | 40.58M |
| 438 | SNSE | Sensei Biotherapeutics, Inc. | 34.92M | 2.98% | 88,866 | - |
| 439 | CRVO | CervoMed Inc. | 34.44M | -5.10% | 52,884 | 4.01M |
| 440 | VERU | Veru Inc. | 33.55M | -5.38% | 80,153 | 16.89M |
| 441 | RNTX | Rein Therapeutics Inc. | 32.86M | 0.79% | 45,583 | - |
| 442 | PLUR | Pluri Inc. | 32.56M | 0.62% | 1,888 | 1.34M |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 32.13M | -1.90% | 182,015 | 90.00K |
| 444 | INMB | INmune Bio Inc. | 29.78M | -6.67% | 375,661 | 50.00K |
| 445 | TVRD | Tvardi Therapeutics, Inc. | 29.74M | -4.80% | 34,193 | - |
| 446 | PDSB | PDS Biotechnology Corporation | 29.63M | -15.42% | 989,247 | - |
| 447 | TLSA | Tiziana Life Sciences Ltd | 29.47M | -0.80% | 179,828 | - |
| 448 | JSPR | Jasper Therapeutics, Inc. | 29.38M | -5.41% | 526,938 | - |
| 449 | EVAX | Evaxion A/S | 29.36M | -1.95% | 30,243 | 7.53M |
| 450 | AEON | AEON Biopharma, Inc. | 29.35M | 16.00% | 299,404 | - |
| 451 | HYPD | Hyperion DeFi, Inc. | 28.72M | -2.01% | 240,842 | 813.46K |
| 452 | XCUR | Exicure, Inc. | 28.14M | -4.23% | 17,533 | 500.00K |
| 453 | QNTM | Quantum BioPharma Ltd. | 27.08M | 24.54% | 463,253 | - |
| 454 | BCTX | BriaCell Therapeutics Corp. | 27.02M | -3.60% | 312,490 | - |
| 455 | LGVN | Longeveron Inc. | 26.94M | -5.44% | 579,010 | 1.20M |
| 456 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.92M | 4.22% | 61,780 | - |
| 457 | KYNB | Kyntra Bio, Inc. | 26.67M | 1.83% | 30,991 | 6.44M |
| 458 | CVM | CEL-SCI Corporation | 25.90M | -7.78% | 58,225 | - |
| 459 | BOLD | Boundless Bio, Inc. | 24.87M | -0.72% | 138,878 | - |
| 460 | ABVC | ABVC BioPharma, Inc. | 24.71M | -4.72% | 75,271 | 797.92K |
| 461 | SNTI | Senti Biosciences, Inc. | 24.61M | -10.36% | 248,780 | 22.00K |
| 462 | DYAI | Dyadic International, Inc. | 24.56M | -3.21% | 207,216 | 3.09M |
| 463 | SER | Serina Therapeutics, Inc. | 24.48M | -13.03% | 734,417 | 130.00K |
| 464 | IGC | IGC Pharma, Inc. | 24.46M | -1.96% | 279,207 | 1.11M |
| 465 | NRSN | NeuroSense Therapeutics Ltd. | 24.41M | -5.06% | 116,778 | - |
| 466 | TPST | Tempest Therapeutics, Inc. | 24.12M | 4.22% | 326,442 | - |
| 467 | CUE | Cue Biopharma, Inc. | 23.38M | -4.58% | 1,140,377 | 27.47M |
| 468 | VTGN | Vistagen Therapeutics, Inc. | 22.56M | -5.87% | 531,950 | 789.00K |
| 469 | BRNS | Barinthus Biotherapeutics plc | 22.47M | 0.04% | 4,465 | 14.97M |
| 470 | CRIS | Curis, Inc. | 22.21M | -4.22% | 465,595 | 9.44M |
| 471 | DARE | Daré Bioscience, Inc. | 22.15M | 2.65% | 266,778 | 1.03M |
| 472 | XTLB | XTL Biopharmaceuticals Ltd. | 22.12M | -4.56% | 6,658 | 968.00K |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 22.10M | -2.38% | 48,948 | 14.99M |
| 474 | OTLK | Outlook Therapeutics, Inc. | 21.77M | -0.90% | 1,930,715 | 205.70K |
| 475 | MRKR | Marker Therapeutics, Inc. | 21.68M | -3.70% | 89,759 | 3.55M |
| 476 | PASG | Passage Bio, Inc. | 20.47M | -7.40% | 47,371 | - |
| 477 | VYNE | VYNE Therapeutics Inc. | 19.70M | -4.26% | 142,937 | 570.00K |
| 478 | NNVC | NanoViricides, Inc. | 19.58M | -5.59% | 150,095 | - |
| 479 | PLRZ | Polyrizon Ltd. | 19.30M | -12.73% | 35,834 | - |
| 480 | SKYE | Skye Bioscience, Inc. | 19.26M | -6.63% | 620,118 | - |
| 481 | LEXX | Lexaria Bioscience Corp. | 18.47M | -1.08% | 146,560 | 522.00K |
| 482 | TVGN | Tevogen Bio Holdings Inc. | 17.67M | -8.30% | 39,419 | - |
| 483 | ALLR | Allarity Therapeutics, Inc. | 17.21M | - | 150,248 | - |
| 484 | KTTA | Pasithea Therapeutics Corp. | 17.09M | -4.88% | 68,761 | - |
| 485 | GNTA | Genenta Science S.p.A. | 16.63M | -14.29% | 1,160,919 | - |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 16.09M | 3.57% | 261,401 | 3.94M |
| 487 | INTS | Intensity Therapeutics, Inc. | 15.28M | -1.31% | 9,764 | - |
| 488 | PHIO | Phio Pharmaceuticals Corp. | 14.64M | - | 290,015 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 14.20M | - | 22,756 | - |
| 490 | TRAW | Traws Pharma, Inc. | 14.06M | -8.81% | 66,148 | 2.85M |
| 491 | IOBT | IO Biotech, Inc. | 13.89M | -5.85% | 664,038 | - |
| 492 | INAB | IN8bio, Inc. | 13.88M | -4.08% | 87,935 | - |
| 493 | HOTH | Hoth Therapeutics, Inc. | 13.10M | -3.97% | 161,886 | - |
| 494 | MBRX | Moleculin Biotech, Inc. | 13.02M | 0.41% | 83,884 | - |
| 495 | GTBP | GT Biopharma, Inc. | 12.90M | -8.32% | 1,127,935 | - |
| 496 | CDT | CDT Equity Inc. | 12.79M | -20.06% | 106,783 | - |
| 497 | BCAB | BioAtla, Inc. | 12.69M | -9.88% | 821,365 | 11.00M |
| 498 | BCDA | BioCardia, Inc. | 12.69M | -0.85% | 35,329 | 3.00K |
| 499 | LTRN | Lantern Pharma Inc. | 12.53M | -46.41% | 7,440,942 | - |
| 500 | KAPA | Kairos Pharma, Ltd. | 12.06M | -1.50% | 38,760 | - |